期刊文献+

儿童马方综合征的心血管并发症及其处理的临床分析 被引量:2

Clinical analysis of cardiovascular complications and management on children Marfan syndrome
下载PDF
导出
摘要 目的:分析儿童马方综合征(MFS)患者心血管并发症及治疗的经验和教训。方法:对我院1998年至2008年收治的28例儿童MFS的临床资料,采用超声心动图,心电图和胸片检查,逐一进行回顾性分析。结果:28例儿童MFS患者中家族史阳性率为35.71%,主动脉窦部扩张的发生率为78.57%,主动脉瓣关闭不全的发生率为39.29%,二尖瓣关闭不全的发生率为71.42%。结论:儿童MFS患者以主动脉窦部扩张为主。存在二尖瓣病变时是否同期处理主动脉依据具体情况确定治疗原则,降低手术风险。 Objective: To analysis cardiovascular complications and management on children Marian syndrome. Method: The clinical data of 28 cases of children Marian syndrome at Anzhen hospital from 1998 to 2008 were analyzed retrospectively by means of echocardiography, ECG and chest X-ray. Result: The family history positive rate was 35.71%, incidence of aortic sinus dilatation was 78.57%, incidence of aortic valve insufficiency was 39.29% and incidence of mitral valve insufficiency was 71.42% in the 28 cases of patients. Conclusion: Children Marian syndrome based mainly aortic sinus dilatation. When they involved mitral valve disease, whether or not management of the aorta disease simultaneously according for actual situation determined principle of treatment, decreased surgical risk.
出处 《心肺血管病杂志》 CAS 2009年第2期97-99,共3页 Journal of Cardiovascular and Pulmonary Diseases
关键词 马方综合征 心脏外科手术 心血管并发症 儿童 Marian syndrome Cardiac surgical procedures Cardiovascular complication Children
  • 相关文献

参考文献11

  • 1Milewicz DM, Dietz HC, Miller DC, et al. Treatment of aortic disease in patients with Marfan syndrome. American Heart Association, 2005, 111 : 150-157.
  • 2李继勇,张健群,孙衍庆.升主动脉成形人工血管外包裹治疗儿童马方综合征[J].心肺血管病杂志,2008,27(1):11-12. 被引量:3
  • 3Patel ND, Williams JA, Barreiro CJ, et al. Valve-sparing aortic root replacement: early experience with the de paulis valsalva graft in 51 patients. Ann Thorac Surg, 2006, 82 : 548-553.
  • 4Ammash NM, Sundt TM, Connolly HM, et al. Marfan syndrome: clinical diagnosis and management. Curr Probl Cardiol, 2008, 33: 724-733.
  • 5谢进生,林多茂,杨毅,乔志钰,徐保卫.83例主动脉根部疾病经典和非经典新术式外科治疗的临床经验和体会[J].心肺血管病杂志,2007,26(3):132-135. 被引量:3
  • 6Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science, 2006, 312: 117-121.
  • 7Ladouceur M, Fermanian C, Lupoglazoff JM, et al. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol, 2007, 99: 406- 409.
  • 8Matt P, Habashi J, Carrel C, et al. Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan? Thorac Cardiovasc Surg, 2008, 135: 389-394.
  • 9Cohn RD, van Erp C, Habashi JP, et al. Angiotensin Ⅱ type 1 receptor blockade attenuates TGF-betainduced failure of muscle regeneration in multiple myopathic states. Nat Med, 2007, 13: 204-210.
  • 10Brooke BS, Habashi JP, Judge DP, et al. Angiotensin Ⅱ blockade and aortic-root dilation in Marfan' s syndrome. N Engl J Med, 2008, 358: 2829-2831.

二级参考文献15

  • 1Gelsomino S,Frassani R,Porreca L,et al.Aortic repair in Marfan's syndrome:prevention of mechanical leaflets damage.Cardiovasc Surg,2001,9:299-301.
  • 2Hagl C,Strauch JT,Spielvogel D,et al.Is the Bentall procedure for ascending aorta or aortic valve replacement the best approach for long-term event-free survival? Ann Thorac Surg,2003,76:698-703.
  • 3Grande-Allen KJ,Cochran RP,Reinhall PG,et al.Recreation of sinuses is important for sparing the aortic valve:a finite element study.J Thorac Cardiovasc Surg,2000,119:753-763.
  • 4Kallenbach K,Karck M,Leyh RG,et al.Valve-sparing aortic root reconstruction in patients with significant aortic insufficiency.Ann Thorac Surg,2002,74:S1765-1799.
  • 5Sioris T,David TE,Ivanov J,et al.Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta.J Thorac Cardiovasc Surg,2004,128:260-265.
  • 6Bentall H,De Bono A.A technique for complete replacement of the ascending aorta.Thorax,1968,23:338-339.
  • 7Zehr KJ,Thubrikar MJ,Gong GG,et al.Clinical introduction of a novel prosthesis for valve preserving aortic root reconstruction for annulo aortic ectasia.J Thorac Cardiovasc Surg,2000,120:692-698.
  • 8Yacoub MH,Gehle P,Chandrasekaran V,et al.Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root.J Thorac Cardiovasc Surg,1998,115:1080-1090.
  • 9David TE,Armstrong S,Ivanov J,et al.Aortic valve sparing operations:an update.Ann Thorae Surg,1999,67:1840-1856.
  • 10Kouchoukos NT,Wareing TH,Murphy SF,et al.Sixteenyear experience with aortic root replacement.Resuhs of 172 operations.Ann Surg,1991,214:308-320.

共引文献2

同被引文献10

  • 1Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 1991,352:337-339.
  • 2Gelb BD. Marfan' s syndrome and related disorders: more tightly connected than we thought. N Engl J Med, 2007,355:841- 844.
  • 3Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan' s syndrome. N Engl J Med, 1994,330 : 1335-1341.
  • 4Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of ena- lapril versus propranolol or atenolol for prevention of aortic dila- tion in patients with the Marfan syndrome. Am J Cardiol, 2005, 95 : 1125-1127.
  • 5Superti-Furga A, Steinmann B, Byers PH. Type Ⅲ collagen de- ficiency. Lancet, 1989, 1:903-904.
  • 6Judge DP,Dietz HC.Marfan’’s syndrome. The Lancet . 2005
  • 7D. M. Milewicz,H. C. Dietz,D. C. Miller.Treatment of aortic disease in patients with Marfan syndrome. Circulation . 2005
  • 8Nistri S,Sorbo MD,Marin M,et al.Aortic root dilation in young men with normally functioning bicuspid aortic valves. Heart . 1999
  • 9Nataatmadja M,Wesa M,West J, et al.Abnormal extracllilar matrix protein transport associated with increased apoptosis of vascular smooth muscel cells in marfan syndrome and bicuspid aortic valve thoracic aprtic aneurysm. Circulation . 2003
  • 10叶祎,韦陈克.儿童马凡综合征临床特点及误诊分析[J].浙江实用医学,2010,15(1):81-82. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部